Why Adaptimmune Therapeutics Stock Is Crashing Today

Why Adaptimmune Therapeutics Stock Is Crashing Today

Shares of the clinical-stage cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) were down by 9.1% as of 2:37 p.m. ET on Wednesday. Earlier today, the biotech's shares were down by an unsightly 12.5% at their low point.